FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

KRSNAA DIAGNOSTICS LTD.

NSE : KRSNAABSE : 543328ISIN CODE : INE08LI01020Industry : Hospital & Healthcare ServicesHouse : Private

BSE715.105.25 (+0.74 %)

PREV CLOSE (Rs.) 709.85

OPEN PRICE (Rs.) 709.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2978

TODAY'S LOW / HIGH (Rs.)704.20 723.05

52 WK LOW / HIGH (Rs.)628 914.95

NSE715.755.55 (+0.78 %)

PREV CLOSE( Rs. ) 710.20

OPEN PRICE (Rs.) 715.55

BID PRICE (QTY) 715.75 (257)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 49315

TODAY'S LOW / HIGH(Rs.) 703.50 725.60

52 WK LOW / HIGH (Rs.)625.75 905

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

21.26

Dividend Yield(%)

0.38

TTM EPS (Rs.)

26.35

P/E Ratio

27.14

Book Value (Rs.)

287.24

Face Value (Rs.)

MCap (Rs. in Mn)

23196.89

Price/Earning (TTM)

13.26

Price/Sales (TTM)

3.32

Price/Book (MRQ)

2.49

PAT Margin (%)

12.15

ROCE (%)

12.96

Incorporation Year : 22-12 2010

Management Info :

Rajendra Mutha - Chairman Yash Mutha - Managing Director

Registered Office :

Address : S. No. 243, A- Hissa No. 6, Cts No. 4519, 4519/1,Near Chinchwad Station Chinchwad,Taluka – Haveli,
Pune,
Maharashtra-411019

Phone : 020-27402400

Email : info@krsnaa.in

Website : www.krsnaadiagnostics.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

06Jan Krsnaa Diagnostics informs about compl
Krsnaa Diagnostics has enclosed the certificate for the quarter ended De..

26Dec Krsnaa Diagnostics informs about closu
Krsnaa Diagnostics has informed that pursuant to SEBI (Prohibition of In..

12Dec Allotment of Debentures
Inter-alia approved the Issuance of Unlisted, Secured, Redeemable and Tr..

Financials

	QTR Sep 25	ANNUAL 25
Net Profit	232.39	828.08
Gross Profit	306.3	1096.02
Operating Profit	622.18	2223.26
Net Sales	1828.82	6816.95

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Nephrocare Health Se (BSE)

509.15 (2.57%)

M.Cap (Rs. in Cr)5108.85

RainbowChildrenS Med (BSE)

1185.85 (0.71%)

M.Cap (Rs. in Cr)12043.39

Vijaya Diagnostic (BSE)

996.20 (0.60%)

M.Cap (Rs. in Cr)9632.71

Lotus Eye Hospital (BSE)

121.95 (4.99%)

M.Cap (Rs. in Cr)253.61

Shareholding Pattern

	NON-INSTITUTION	54.85%
	PROMOTERS	27.11%
	MUTUAL FUNDS/UTI	10.15%
	FI/BANKS/INSURANCE	2.67%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Tata Small Cap Fund...

1.58

Kotak Healthcare Fu...

1.56

Bandhan Small Cap F...

0.29

Bandhan BSE Healthc...

0.10

Motilal Oswal BSE H...

0.10

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

KRSNAA DIAGNOSTICS LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives